Search -

Displaying 101 - 120 of 124

Sort: Relevancy | Date

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

News Daily News

Respiratory Syncytial Virus Linked With Cardiovascular Complications

Michael O'Riordan

April 04, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Conference News ACC 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Michael O'Riordan

March 12, 2018

News Daily News

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Michael O'Riordan

January 24, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Conference News AHA 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Yael L. Maxwell

November 13, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

Caitlin E. Cox

August 31, 2017

Presentation ESC 2017

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Presenter: Paul M. Ridker

August 27, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

CANTOS: Canakinumab Cuts MI, Stroke in Post-MI Patients With Elevated CRP

News Daily News

CANTOS: Canakinumab Cuts Combo of MI, Stroke, CV Death in Post-MI Patients With Elevated CRP

Todd Neale

June 22, 2017

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

News Conference News ACC 2017

ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s

Yael L. Maxwell

March 17, 2017

News Daily News

Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started

Todd Neale

December 05, 2016

News Conference News AHA 2016

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Shelley Wood

November 13, 2016

News Conference News AHA 2016

Cardiac Arrest Survival Higher in Patients Already Taking Statins

Todd Neale

November 12, 2016

News Daily News

Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows

Michael O'Riordan

September 30, 2016

Advertisement

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Respiratory Syncytial Virus Linked With Cardiovascular Complications

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

TCTMD’s Top 10 Most Popular Stories for August 2017

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

CANTOS: Canakinumab Cuts Combo of MI, Stroke, CV Death in Post-MI Patients With Elevated CRP

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s

Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Cardiac Arrest Survival Higher in Patients Already Taking Statins

Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content